Perioperative and postoperative patient outcomes
| Total (n = 353) | No DM after PD (n = 178) | New-onset DM after PD (n = 64) | ||
|---|---|---|---|---|
| Operation time (min) | 561.0 ± 101.0 | 560.0 ± 100.9 | 580.3 ± 112.7 | 0.185 |
| Length of postoperative hospital stay (day) | 20.1 ± 18.0 | 20.6 ± 22.4 | 21.6 ± 16.8 | 0.739 |
| Pancreaticojejunostomy stent | 0.563 | |||
| External stent | 285 (80.7) | 145 (81.4) | 50 (78.1) | |
| Internal stent | 68 (19.3) | 33 (18.6) | 14 (21.9) | |
| Postoperative pancreatic fistula | 177 (50.1) | 94 (52.8) | 34 (53.2) | 0.181 |
| Grade A | 98 (27.8) | 56 (31.5) | 14 (21.9) | |
| Grade B | 77 (21.8) | 38 (21.3) | 20 (31.3) | |
| Grade C | 2 (0.6) | 0 (0) | 0 (0) | |
| Grade B or C | 79 (22.4) | 38 (21.3) | 20 (31.3) | |
| Adjuvant chemotherapy | 220 (62.3) | 99 (55.6) | 41 (64.0) | 0.390 |
| Gemcitabine | 150 (42.5) | 60 (33.7) | 30 (46.8) | |
| 5-fluorouracil, leucovorin | 51 (14.4) | 28 (15.7) | 6 (9.3) | |
| 5-fluorouracil, leucovorin, irinotecan, oxaliplatin | 7 (2.0) | 5 (2.8) | 2 (3.1) | |
| Others | 12 (3.4) | 6 (3.3) | 3 (4.7) | |
| Malignancy | 318 (90.1) | 161 (90.4) | 55 (85.9) | 0.317 |
| Combined chronic pancreatitis | 10 (2.8) | 5 (2.8) | 2 (3.1) | 0.345 |
Values are expressed as mean ± standard deviation or number (%).
DM, diabetes mellitus; PD, pancreaticoduodenectomy.
a)